Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 9Lymphoma, Non-Hodgkin 6Neoplasms, Plasma Cell 4Leukemia 4Hodgkin Disease 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Stomatitis 2Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Acute 2Drug-Related Side Effects and Adverse Reactions 2Burkitt Lymphoma 2Blast Crisis 2Sezary Syndrome 1Recurrence 1Radiation Injuries 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms 1Myeloproliferative Disorders 1Mycosis Fungoides 1Mucositis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Fibroblast Growth Factor 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cataract × Fibroblast Growth Factor 7 × Plasma cell × Clear all
NCT00434161 2015-03-30

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

Swedish Orphan Biovitrum

Phase 3 Completed
281 enrolled 27 charts
Plasma cell

Cataract, Multiple Myeloma, Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡